Objective Medicaid recipients are vulnerable to increased morbidity and mortality secondary to high tobacco use prevalence and barriers to accessing tobacco treatment. The purpose of the pilot study was to explore managed care administrators' perceptions of the facilitators and barriers to tobacco treatment for Medicaid recipients. Methods Focus groups with key informants (n = 14) from managed care organizations were conducted in fall 2018. Participants included case, integrated care, quality and field care managers, and individuals working in provider and network relations. Results Facilitators to tobacco treatment were universal quality reporting requirements, access to medications, and the role of case management in identifying and engaging tobacco users in treatment. Barriers included bias regarding smokers' ability to quit, communication challenges, and competing priorities. Conclusions The analysis provided data to support the development of a policy brief and recommendations to the Department for Medicaid Services for enhancing tobacco dependence treatment.

Original languageEnglish
Pages (from-to)603-610
Number of pages8
JournalSouthern Medical Journal
Issue number8
StatePublished - Aug 1 2022

Bibliographical note

Publisher Copyright:
© Lippincott Williams & Wilkins.


  • Medicaid
  • policy
  • smoking cessation
  • tobacco use

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Enhancing Tobacco Treatment for Medicaid Recipients'. Together they form a unique fingerprint.

Cite this